Naohiro Sekiguchi

Pembrolizumab versus brentuximab vedotin in relapsed or refractory classical Hodgkin lymphoma (KEYNOTE-204): an interim analysis of a multicentre, randomised, open-label, phase 3 study

John Kuruvilla, Radhakrishnan Ramchandren, Armando Santoro et al. · The Lancet Oncology · 2021 · 258 citations

Medicine, Oncology, Pharmacology +15

Long-term follow-up results of no initial therapy for ocular adnexal MALT lymphoma

Kazuki Tanimoto, Akihiro Kaneko, Shigenobu Suzuki et al. · Annals of Oncology · 2005 · 114 citations · Full text

Medicine, Oncology, Ophthalmology +10

A multicenter, open‐label, phase II study of tirabrutinib (ONO/GS‐4059) in patients with Waldenström’s macroglobulinemia

Naohiro Sekiguchi, Shinya Rai, Wataru Munakata et al. · Cancer Science · 2020 · 77 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

Primary Ocular Adnexal MALT Lymphoma: A Long-term Follow-up Study of 114 Patients

Kazuki Tanimoto, Akihiro Kaneko, Shigenobu Suzuki et al. · Japanese Journal of Clinical Oncology · 2007 · 64 citations · Full text

Medicine, Oncology, Pathology +11

Fluorescence in situhybridization (FISH) analysis of primary ocular adnexal MALT lymphoma

Kazuki Tanimoto, Naohiro Sekiguchi, Yukiko Yokota et al. · BMC Cancer · 2006 · 49 citations · Full text

Medicine, Oncology, Pathology +17